A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (Q113927854)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
clinical trial

    Statements

    PATHFNDR-1 (English)
    0 references
    A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects With Acromegaly Treated With Long-acting Somatostatin Receptor Ligands (PATHFNDR-1) (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    12 May 2021
    0 references
    June 2023
    0 references
    52
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit